Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marathon Group appears to refer primarily to a diversified investment and holding company rather than a dedicated life sciences operating company. Publicly available information indicates it has invested in multiple sectors including pharmaceuticals, retail, agriculture, infrastructure, and consumer businesses, with pharmaceutical assets housed through a sub-holding called Marathon Pharma. The entity was founded in 2017 and is associated with Moscow, Russia. While it has had exposure to healthcare and pharmaceutical assets, the parent company itself does not appear to be a biotech, pharma, or healthcare developer with a therapeutic pipeline. Because the requested name is highly ambiguous and maps to multiple unrelated organizations, this record reflects the Russian investment group that has had pharma-related holdings, not an exact life sciences company match.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marathon Group.